# Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors

> **NCT00415116** · PHASE1 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 14 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** carboplatin
- **DRUG:** docetaxel
- **DRUG:** lenalidomide

## Key facts

- **NCT ID:** NCT00415116
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2011-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00415116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00415116, "Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00415116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*